IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 1 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,065,828 | -21.9% | 39,804 | -9.7% | 0.96% | -21.0% |
| Q2 2023 | $2,643,876 | +305.3% | 44,094 | +234.2% | 1.21% | +127.9% |
| Q1 2023 | $652,311 | -13.4% | 13,194 | 0.0% | 0.53% | +18.8% |
| Q4 2022 | $752,982 | -3.3% | 13,194 | -20.5% | 0.45% | +0.4% |
| Q3 2022 | $779,000 | – | 16,588 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
| Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
| Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
| Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
| Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
| RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
| Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
| Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
| Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |